UTR Therapeutics Inc. has submitted an IND application to the FDA for UTRxM1-18, a novel therapeutic approach for targeting c-MYC-driven cancers. Pending approval, a first-in-human phase I trial is ...
Rafael Nadal's 21-match clay winning streak came to an end in the Madrid quarterfinals, but he's still the King of Clay, especially with his 16.41 clay-court UTR. A Universal Tennis Rating, or UTR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback